Sopharma : Consolidated financial results for the first half of 2021

Sopharma Group

Consolidated financial results for the first half of 2021

Consolidated financial results for the first half of 2021

Who are we?

Sopharma Group

The Group is a leading, vertically-integrated Bulgarian manufacturer, exporter and distributor of

pharmaceutical and other health related products with a strong presence in Southern and Eastern Europe, offering a wide range of prescription and OTC pharmaceutical products and other health related products and services.

The Group works in the following areas:

• Production of active pharmaceutical ingredients;

• Pharmaceutical production;

• Wholesale and distribution;

• Non-pharmaceutical activities.

"Sopharma" AD

Bulgarian based mother company,

pharmaceutical producer

API production

Farmer, Bulgaria

Farming of

medicinal plants

"Sopharma" AD ,

Kazanlak Bulgaria

Extraction of active

ingredients

Pharmaceuticals

production

"Sopharma" AD , Bulgaria Self-developedproducts from herbal origin, Generic products

"Biopharm Engineering"

AD, Bulgaria and PAO

"Vitamini" Ukraine

Generic products

Veterinary products

Wholesale and

distribution

"Sopharma Trading" AD,

Bulgaria and Serbia

Pre-wholesaling, wholesaling, retail

"BRIZ" Latvia and

Sopharma 100% owned subsidiaries in Ukraine, Kazakhstan, Poland and etc.

Wholesaling, retail

Non-pharma activities

"Biopharm Engineering"

AD

Veterinary products, sterile

production

"Momina Krepost" AD

Plastic disposable materials

Brief history and key milestones:

• Local pharmaceutical community starts construction of the first laboratory for production of medicinal products

• Privatization -		•	Licensed its production
		facilities according to the
"Sopharma" AD			European GMP
becoming a		•	Increased production capacity	• Listing on Warsaw
privately held			through acquisition of
pharmaceutical	•	New modern	"Bulgarian Rose Sevtopolis" AD	Stock Exchange
company		pharmaceutical
		plant Vrabevo	• Acquired a very
		opened for	active distributor
		production of	"Briz" OOD in
		medicinal	Latvia
		products

• Transformation
through merger	• First generic
between "Medica" AD	in urology -
and "Sopharma" AD	Urimax Duo

• Transformation

	through merger	•	"Sopharma"AD
	between
		sold the shares
	"Unipharm" AD and
		owned by it
	"Sopharma" AD
• Focus on		from the capital
		of "Aromania"
R&D
			AD

1933

1953

1999

2000

2002

2003

2004

2005

2006

2009

2011

2013

2014

2017

2018

2019

2020

• "Sopharma" AD nationalized

Start of production:

• 1956 - Nivalin

• 1964 - Tabex

• 1981 - Tribestan
• • "Sopharma" AD listed on BSE.

Acquired five small			• Construction of new production		"Sopharma Trading" AD
	producers:	•	Opened the state-of-
	facilities in Sofia and Serbia		acquires sole control
•	"Unipharm" AD		the-art logistics
	• First successful registration of
•	"Vramed" AD		terminal for		over the companies
	Sopharma's product in old EU
•	"Pharmachim Holding" AD	distribution of		"SCS Franchise" AD and
(Nivalin in Austria)
•	"NIHFI" AD		pharmaceutical		"Sanita Franchising" AD
	• Control stake acquisition in
•	"Rostbalkanpharm"		products (European
	"Unifarm" AD
			GDP certified)	•	"Sopharma"

• Penetrating into distribution	AD celebrates
its 85th
business by acquiring "Sopharma
anniversary
Trading" AD

Modern history - period of constant modernization and development